MedPath

Linear Focused Shockwave Treatment for Erectile Dysfunction

Not Applicable
Terminated
Conditions
Vasculogenic Erectile Dysfunction
Interventions
Device: Renova
Registration Number
NCT02152683
Lead Sponsor
Initia
Brief Summary

The study is aimed at comparing the performance of protocols employing one and two sessions per week, respectively. The study hypothesis claims that there is no significant difference between the performances of the compared protocols.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
84
Inclusion Criteria
  1. Good general health
  2. Vasculogenic ED- Erectile Dysfunction, according to physician judgment, for at least 6 months and for no longer than 5 years.
  3. International Index of Erectile Function 6 (IIEF-EF) between 17 and 25
  4. Satisfactory response to the use of PDE5 (Phosphodiesterase type 5) inhibitors
  5. Stable sexual relationship for at least 3 months prior to treatment
  6. Minimum of two sexual attempts per month
Exclusion Criteria
  1. Hormonal, neurological or psychological pathology
  2. Past radical prostatectomy or extensive pelvic surgery
  3. Recovering from cancer during last year
  4. Any unstable medical, psychiatric, spinal cord injury and penile anatomical abnormalities
  5. Clinically significant chronic hematological disease
  6. Anti-androgens, oral or injectable androgens
  7. Past radiotherapy treatment of the pelvic region
  8. International normalized ratio (INR) > 3 for patients using blood thinners (such as Coumadin)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
short protocolRenovaRenova
long protocolRenovaRenova
Primary Outcome Measures
NameTimeMethod
IIEF-EF- International Index of Erectile Function questionnaire score1 month post treatment

the IIEF-EF questionnaire score will be evaluated at baseline, 1,3, and 6 months after end of treatment

IIEF-EF questionnaire score6 months post treatment

the IIEF-EF questionnaire score will be evaluated at baseline, 1,3, and 6 months after end of treatment

Secondary Outcome Measures
NameTimeMethod
GAQ- Global Assessment Questions1, 3 and 6 months post treatment
SEP- Sexual Encounter Profile: Questions 2 and 31, 3 and 6 months post treatment
EHS- Erection Hardness Score1, 3 and 6 months post treatment

Trial Locations

Locations (1)

Eastchester Center for Cancer Care

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath